To include your compound in the COVID-19 Resource Center, submit it here.

Dapagliflozin: Additional Phase III data

Data from 339 Type II diabetics inadequately controlled with metformin in the 78-week extension of a 24-week, double-blind Phase III trial showed that 2.5, 5 and 10 mg

Read the full 287 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE